Thus, similar to our observations in the PDX models, it seems that while most patients exhibit a low to medium expression of CXCL1, CSF2, and IL-1β, a fraction of breast cancer patients exhibit high expression levels of these cytokines. The gene discussed is CSF2; the disease is breast carcinoma.